ESCORSELL MAÑOSA, Mª ANGELS FGS
MEscorsell@santpau.cat
Bertoletti , Federico FGS
Brujats Rubirola, Anna FGS
Concepcion Martin, Maria Del Mar FGS
Cuyas Espi, Berta FGS
Gallego Moya, Adolfo FGS
Garcia Planella, Esther FGS
Giordano, Antonio IR
Gomez Oliva, Cristina FGS
Gonzalez Juan, Dolores FGS
Gonzalez Muñoza, Carlos FGS
Gordillo Abalos, Jorge FGS
Guarner Aguilar, Carlos FGS
Guarner Argente, Carlos FGS
Murzi Pulgar, Marianette Carolina FGS
Oblitas Susanibar, Elida FGS
Poca Sans, Maria FGS
Pujol Camps, Claudia FGS
Roig Ramos, Cristina FGS
Roman Abal, Eva Maria FGS
Romero Mascarell, Cristina FGS
Romito, Raffaella FGS
Sainz Saenz-torre, Sergio FGS
Sanchez Ardid, Elisabet CIBEREHD
Soriano Pastor, German FGS
Torras Colell, Javier FGS
Villanueva Sanchez, Candid FGS
Albeniz E., Gimeno-Garcia A.Z., Fraile M., Ibanez B., Guarner-Argente C., Alonso-Aguirre P., Alvarez M.A., Gargallo C.J., Pellise M., Ramos Zabala F., Herreros de Tejada A., Nogales O., Martinez-Ares D., Mugica F., de la Pena J., Espinos J., Huerta A., Alvarez A., Gonzalez-Santiago J.M., Navajas F., Martinez-Cara J.G., Redondo-Cerezo E., Merlo Mas J., Sabado F., Rivero L., Saperas E., Soto S., Rodriguez-Sanchez J., Lopez-Roses L., Rodriguez-Tellez M., Rullan Iriarte M., Elosua Gonzalez A., Pardeiro R., Valdivielso Cortazar E., Concepcion-Martin M., Huelin Alvarez P., Colan Hernandez J., Cobian J., Santiago J., Jimenez A., Remedios D., Lopez-Viedma B., Garcia O., Martinez-Alcala F., Perez-Roldan F., Carbo J., Enguita M. (2020) Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions. GASTROINTEST ENDOSC, 91 (4), 868-878.e3.
IF: 9,427
Algaba A, Guerra I, Ricart E, Iglesias E, Mañosa M, Gisbert JP, Guardiola J, Mínguez M, Castro B, de Francisco R, Nos P, Bertoletti F, Mesonero F, Barrio J, Martín-Arranz MD, Calvet X, et al. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry. DIGEST DIS SCI. 2020 Jul. doi: 10.1007/s10620-020-06424-x. PMID: 326787.
IF: 3,199
Alvarado-Tapias E., Ardevol A., Garcia-Guix M., Montanes R., Pavel O., Cuyas B., Graupera I., Brujats A., Vilades D., Colomo A., Poca M., Torras X., Guarner C., Concepcion M., Aracil C., Torres F., Villanueva C. (2020) Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. J HEPATOL, 73 (4), 829-841.
IF: 25,083
Ampuero J., Aller R., Gallego-Duran R., Crespo J., Calleja J.L., Garcia-Monzon C., Gomez-Camarero J., Caballeria J., Lo Iacono O., Ibanez L., Garcia-Samaniego J., Albillos A., Frances R., Fernandez-Rodriguez C., Diago M., Soriano G., Andrade R.J., Latorre R., Jorquera F., Morillas R.M., Escudero D., Estevez P., Guerra M.H., Augustin S., Banales J.M., Aspichueta P., Benlloch S., Rosales J.M., Salmeron J., Turnes J., Romero Gomez M. (2020) Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. J HEPATOL, 73 (1), 17-25.
IF: 25,083
Ampuero J, Pais R, Aller R, Gallego-Durán R, Crespo J, García-Monzón C, Boursier J, Vilar E, Petta S, Zheng MH, Escudero D, Calleja JL, Aspichueta P, Diago M, Rosales JM, Caballería J, Gómez-Camarero J, Lo Iacono O, Benlloch S, Albillos A, Turnes J, Banales JM, Ratziu V, Romero-Gómez M; HEPAmet Registry. Development and Validation of Hepamet IFbrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced IFbrosis. CLIN GASTROENTEROL HEPATOL. 2020 Jan;18(1):216-225.e5. doi: 10.1016/j.cgh.2019.05.051. PMID: 31195161.
IF: 11,382
Ardevol A., Alvarado-Tapias E., Garcia-Guix M., Brujats A., Gonzalez L., Hernandez-Gea V., Aracil C., Pavel O., Cuyas B., Graupera I., Colomo A., Poca M., Torras X., Concepcion M., Villanueva C. (2020) Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation. DIGEST LIVER DIS, 52 (9), 1017-1025.
IF: 4,088
Ausania F., Senra Del Rio P., Borin A., Guzman Suarez S., Rivera Irigoin R., Fort Martorell E., Concepcion-Martin M., del Val Antonana A., Ferrandez A., Grau Garcia F.J., Ruiz Rebollo M.L., Andreu E.B., de-Madaria E. (2020) Factors associated with mortality in patients with infected pancreatic necrosis: the “surgery effect”. UPDATES SURG, 72 (4), 1097-1103.
IF: 2,797
Canete, Forella; Manosa, Miriam; Perez-Martinez, Isabel; Barreiro-de Acosta, Manuel; Gonzalez-Sueyro, Ramiro; Nos, Pilar, Iglesias-Flores, Eva; Gutierrez, Ana; Bujanda, Luis; Gordillo, Jordi. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn’s Disease: A Nationwide Study With Propensity-Matched Score Analysis. INFLIRECU Study Volumen11:, AUG 2020. CLIN TRANSL GASTROENTEROL 2020 Aug; 11(8): e00218. doi: 10.14309/ctg.0000000000000218. PMID: 32955190.
IF: 4,488
Casanova M.J., Chaparro M., Minguez M., Ricart E., Taxonera C., Garcia-Lopez S., Guardiola J., Lopez-San Roman A., Iglesias E., Beltran B., Sicilia B., Vera M.I., Hinojosa J., Riestra S., Domenech E., Calvet X., Perez-Calle J.L., Martin-Arranz M.D., Aldeguer X., Rivero M., Monfort D., Barrio J., Esteve M., Marquez L., Lorente R., Garcia-Planella E., de Castro L., Bermejo F., Merino O., Rodriguez-Perez A., Martinez-Montiel P., Van Domselaar M., Alcain G., Dominguez-Cajal M., Munoz C., Gomollon F., Fernandez-Salazar L., Garcia-Sepulcre M.F., Rodriguez-Lago I., Gutierrez A., Arguelles-Arias F., Rodriguez C., Rodriguez G.E., Bujanda L., Llao J., Varela P., Ramos L., Huguet J.M., Almela P., Romero P., Navarro-Llavat M., Abad A., Ramirez-de la Piscina P., Lucendo A.J., Sese E., Madrigal R.E., Charro M., Garcia-Herola A., Pajares R., Khorrami S., Gisbert J.P. (2020) Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry. INFLAMM BOWEL DIS, 26 (4), 606-616.
IF: 5,325
Chaparro M., Gordillo J., Domenech E., Esteve M., Barreiro-de Acosta M., Villoria A., Iglesias-Flores E., Blasi M., Naves J.E., Benitez O., Nieto L., Calvet X., Garcia-Sanchez V., Villagrasa J.R., Marin A.C., Donday M.G., Abad-Santos F., Gisbert J.P. (2020) Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. AM J GASTROENTEROL, 115 (11), 1802-1811.
IF: 10,864
Chen Q, Perales C, Soria ME, García-Cehic D, Gregori J, Rodríguez-Frías F, Buti M, Crespo J, Calleja JL, Tabernero D, Vila M, Lázaro F, Rando-Segura A, Nieto-Aponte L, Llorens-Revull M, Cortese MF, Fernandez-Alonso I, Castellote J, Niubó J, Imaz A, et al. Deep-sequencing reveals broad subtype-speciIFc HCV resistance mutations associated with treatment failure. ANTIVIRAL RES.;174:104694. doi 10.1016/j.antiviral.2019.104694. PMID: 31857134.
IF: 5,970
Colan-Hernandez J., Sendino O., Loras C., Pardo A., Gornals J.B., Concepcion M., Sanchez-Montes C., Murzi M., Andujar X., Velasquez-Rodriguez J., Rodriguez de Miguel C., Fernandez-Esparrach G., Gines A., Guarner-Argente C. (2020) Antibiotic Prophylaxis Is Not Required for Endoscopic Ultrasonography-Guided Fine-Needle Aspiration of Pancreatic Cystic Lesions, Based on a Randomized Trial. GASTROENTEROLOGY, 158 (6), 1642-1649.e1.
IF: 22,682
Diaz-Gonzalez A., Sanduzzi-Zamparelli M., da Fonseca L.G., Di Costanzo G.G., Alves R., Iavarone M., Leal C., Sacco R., Matilla A.M., Hernandez-Guerra M., Aballay Soteras G., Worns M.-A., Pinter M., Varela M., Ladekarl M., Chagas A.L., Minguez B., Arenas J.I., Granito A., Sanchez-Torrijos Y., Rojas A., Rodriguez de Lope C., Alvares-da-Silva M.R., Pascual S., Rimassa L., Lledo J.L., Huertas C., Sangro B., Giannini E.G., Delgado M., Vergara M., Perello C., Lue A., Sala M., Gallego A., Coll S., Hernaez T., Pinero F., Pereira G., Franca A., Marin J., Anders M., Mello V., Lozano M., Nault J.C., Menendez J., Garcia Juarez I., Bruix J., Reig M. (2020) International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis. LIVER INT, 40 (6), 1467-1476.
IF: 5,828
Fernandez J., Angeli P., Trebicka J., Merli M., Gustot T., Alessandria C., Aagaard N.K., de Gottardi A., Welzel T.M., Gerbes A., Soriano G., Vargas V., Albillos A., Salerno F., Durand F., Banares R., Stauber R., Prado V., Arteaga M., Hernandez-Tejero M., Aziz F., Morando F., Jansen C., Lattanzi B., Moreno C., Campion D., Gronbaek H., Garcia R., Sanchez C., Garcia E., Amoros A., Pavesi M., Claria J., Moreau R., Arroyo V. (2020) Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. CLIN GASTROENTEROL H, 18 (4), 963-973.e14.
IF: 11,382
García-Rayado G, Varela-Moreiras G, Lanas Á, Ferrández Á, Balza-Lareu N, Cervera JI, Bodenlle-Bello MP, Argüelles-Arias AM, Latorre P, Udaondo-Cascante MA, Soria-de-la-Cruz MJ, Lariño-Noia J, García-IFgueiras R, Gil-García-Ollauri C, Ituarte-Uriarte R, Rosales-Alexander C L, Soriano J, Rodríguez-Peláez M, Mesa-Álvarez A, Oblitas E, Menso MM, Bertoletti F, Rodríguez-Prada JI, Guzmán-Suárez S, Closa D, de-Madaria E. Dietary Fat Patterns and Outcomes in Acute Pancreatitis in Spain. FRONT MED (LAUSANNE), 2020 Apr 9;7:126. doi: 10.3389/fmed.2020.00126. PMID: 32328495.
IF: 5,091
Gely C., Marin L., Gordillo J., Manosa M., Bertoletti F., Canete F., Gonzalez-Munoza C., Calafat M., Domenech E., Garcia-Planella E. (2020) Impact of pain associated with the subcutaneous administration of adalimumab Impacto del dolor asociado a la administración subcutánea de adalimumab. GASTROENT HEPAT-BARC, 43 (1), 9-13.
IF: 2,102
Guasch M., Canete F., Ordas I., Iglesias-Flores E., Clos A., Gisbert J.P., Taxonera C., Vera I., Minguez M., Guardiola J., Rivero M., Nos P., Gomollon F., Barrio J., de Francisco R., Lopez-Sanroman A., Martin-Arranz M.D., Garcia-Planella E., Camargo R., Garcia-Lopez S., de Castro L., Calvet X., Esteve M., Manosa M., Domenech E. (2020) Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. J GASTROEN HEPATOL, (), -.
IF: 4,029
Iborra M, Beltrán B, Fernández-Clotet A, Iglesias-Flores E, Navarro P, Rivero M, Gutiérrez A, Sierra-Ausin M, Mesonero F, Ferreiro-Iglesias R, Hinojosa J, Calvet X, Sicilia B, González-Muñoza C, Antolín B, González-Vivo M, Carbajo A Y, García-López S, Martín-Cardona A, Surís G, Martin-Arranz MD, de Francisco R, Cañete I, Domènech E, Nos P, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa). Real-world long-term effectiveness of ustekinumab in Crohn’s disease: results from the ENEIDA registry. ALIMENT PHARM THER. 2020 Sep;52(6):1017-1030. doi: 10.1111/apt.15958. PMID 32770851.
IF: 8,171
Iborra M., Garcia-Morales N., Rubio S., Bertoletti F., Calvo M., Taxonera C., Bosca-Watts M.M., Sierra M., Mancenido N., Beltran B., Nantes Castillejo O., Garcia-Planella E., Vera I., Alba C., Marti-Aguado D., Ballester M.P., Cano-Sanz N., Pajares-Villarroya R., Cerrillo E., Canada A., Nos P. (2020) Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients. SCI REP-UK, 10 (1), -.
IF: 4,379
La Mura V, Garcia-Guix M, Berzigotti A, Abraldes JG, García-Pagán JC, Villanueva C, Bosch J. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk StratiIFcation After Variceal Bleeding. HEPATOLOGY. 2020 Oct;72(4):1353-1365. doi: 10.1002/hep.31125. PMID: 31960441.
IF: 17,425
La Mura V, Villanueva C, Abraldes JC, Bosch J. A Prognostic Algorithm Based on Stage of Cirrhosis and Hepatic Venous Pressure Gradient to Improve Risk Stratification After Variceal Bleeding Repley. (letter to the editor). HEPATOLOGY. 2020 Oct;72(4):1494-1495. doi: 10.1002/hep.31253.PMID: 32246502.
IF: 17,425
Lens S., Baiges A., Alvarado-Tapias E., LLop E., Martinez J., Fortea J.I., Ibanez-Samaniego L., Marino Z., Rodriguez-Tajes S., Gallego A., Banares R., Puente A., Albillos A., Calleja J.L., Torras X., Hernandez-Gea V., Bosch J., Villanueva C., Garcia-Pagan J.C., Forns X. (2020) Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. J HEPATOL, 73 (6), 1415-1424.
IF: 25,083
Melcarne L, Sánchez Vilanova A, Guarner-Argente C. Hypertensive panesophageal pressurization in type II achalasia. (letter) Rev Esp Enferm Dig. 2020 Jan;112(1):76. doi: 10.17235/reed.2019.6414/20. PMID: 31823638.
IF: 2,086
Mellado, FJL; Pardal, LP; Feliu, IC, Tora-Rocamora; Rofastes, MC; Diaz, ER; Ortiz, MP; Bravo, JCC; Aldea, M; Cano, JG, Abos-Herrandiz, R, Abril, E; Alvarez, C; Alvarez, MA; Andreu, M; Araujo, I; Auge, JM; Aymar, A; Bagaria, G; Balaguer, F; Bessa, X; et al. Impact of a Primary Care intervention on the colorectal cancer early detection programme. GASTROENTEROLOGIA Y HEPATOLOGIA; Volumen: 42 Número: 6 Páginas: 351-361. doi: 10.1016/j.gastrohep.2019.01.007. PMID: 30954319.
IF: 2,102
Moreau R., Claria J., Aguilar F., Fenaille F., Lozano J.J., Junot C., Colsch B., Caraceni P., Trebicka J., Pavesi M., Alessandria C., Nevens F., Saliba F., Welzel T.M., Albillos A., Gustot T., Fernandez J., Moreno C., Baldassarre M., Zaccherini G., Piano S., Montagnese S., Vargas V., Genesca J., Sola E., Bernal W., Butin N., Hautbergue T., Cholet S., Castelli F., Jansen C., Steib C., Campion D., Mookerjee R., Rodriguez-Gandia M., Soriano G., Durand F., Benten D., Banares R., Stauber R.E., Gronbaek H., Coenraad M.J., Gines P., Gerbes A., Jalan R., Bernardi M., Arroyo V., Angeli P. (2020) Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J HEPATOL, 72 (4), 688-701.
IF: 25,083
Murzi M., Gordillo J., Oblitas E., Soriano G., Pernas J.C., Posso M., Garcia-Planella E. (2020) Spontaneous hepatic portal venous gas in a patient with ulcerative colitis. A case report and a review Gas venoso portal hepático espontáneo en un paciente con colitis ulcerosa. Reporte de un caso y revisión. GASTROENT HEPAT-BARC, 43 (1), 22-25.
IF: 2,102
Puigvehi M., Londono M.-C., Torras X., Lorente S., Vergara M., Morillas R.M., Masnou H., Serrano T., Miquel M., Gallego A., Lens S., Carrion J.A. (2020) Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV–cirrhotic patients. J GASTROENTEROL, 55 (2), 205-216.
IF: 7,527
Rivero-Sánchez L, Arnau-Collell C, Herrero J, Remedios D, Cubiella J, García-Cougil M, Alvarez V, Albéniz E, Calvo P, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, et al. White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study. GASTROENTEROLOGY 2020 Mar;158(4):895-904.e1. doi: 10.1053/j.gastro.2019.09.003. PMID: 31520613.
IF: 22,682
Rivero-Sánchez L, Gavric A, Herrero J, Remedios D, Alvarez V, Albéniz E, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez C, Arnau-Collell C, Ortiz O, Sánchez A, Jung G, Balaguer F, Pellisé M. The “diagnose and leave in” strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. ENDOSCOPY. 2020 Dec 3. doi: 10.1055/a-1328-5405. PMID: 33271604.
IF: 10,093
Rodríguez de Santiago E, Aldehuelo RS, Pons FR, Escaja CR, Fernández-Esparrach G, Ángel Cañete-Ruiz, Aracil CF, Pérez-Corte D, León RR, Marcos-Prieto HM, Delgado-Guillena PG, García-Rodríguez A, Guarner-Argente C, Muriel A, Fuente-Briongos E, et al. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clin Gastroenterol Hepatol. 2020 Dec 4: S1542-3565(20)31627-X. doi: 10.1016/j.cgh.2020.11.037. PMID: 33279783.
IF: 11,382
Rodriguez-Lago I., Castro-Poceiro J., Fernandez-Clotet A., Mesonero F., Lopez-Sanroman A., Lopez-Garcia A., Marquez L., Clos-Parals A., Canete F., Vicuna M., Nantes O., Merino O., Matallana V., Gordillo J., Elorza A., Vicente R., Casanova M.J., Ferreiro-Iglesias R., Perez-Galindo P., Benitez J.M., Taxonera C., Garcia M.J., Martin E., Aguirre U., Gisbert J.P. (2020) Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease. ALIMENT PHARM THER, 51 (9), 870-879.
IF: 8,171
Rodríguez-Tajes S, Domínguez Á, Carrión JA, Buti M, Quer JC, Morillas RM, López C, Torras X, Baliellas C, Vergara M, Forner M, Zaragoza N, Salò J, Rigau J, Caballeria L, Mariño Z, Janè M, Colom J, Forns X, Lens S. SigniIFcant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. J Gastroenterol Hepatol. 2020 Jan 20. doi: 10.1111/jgh.14984. PMID: 31957902.
IF: 4,029
Román E, Parramón M, Flavià M, Gely C, Poca M, Gallego A, Santesmases R, Hernández E, Nieto JC, Urgell E, Alvarado-Tapias E, Vidal S, Ferrero-Gregori A, Vargas V, Guarner C, Soriano G. Frailty in outpatients with cirrhosis: A prospective observational study. LIVER INT. 2021 Feb;41(2):357-368. doi: 10.1111/liv.14694. PMID: 33030788.
IF: 5,828
Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, Giovo I, Uschner FE, Jansen C, Jimenez C, Mookerjee R, Gustot T, Albillos A, Bañares R, Jarcuska P, Steib C, Reiberger T, Acevedo J, Gatti P, Shawcross DL, Zeuzem S, Zipprich A, Piano S, et al. PREDICT identiIFes precipitating events associated with the clinical course of acutely decompensated cirrhosis. J HEPATOL. 2020 Nov 20:S0168-8278(20)33772-7. doi: 10.1016/j.jhep.2020.11.019. PMID: 33227350.
IF: 25,083
Trebicka J., Gu W., Ibanez-Samaniego L., Hernandez-Gea V., Pitarch C., Garcia E., Procopet B., Giraldez A., Amitrano L., Villanueva C., Thabut D., Silva-Junior G., Martinez J., Genesca J., Bureau C., Llop E., Laleman W., Palazon J.M., Castellote J., Rodrigues S., Gluud L., Ferreira C.N., Barcelo R., Canete N., Rodriguez M., Ferlitsch A., Mundi J.L., Gronbaek H., Hernandez-Guerra M., Sassatelli R., Dell'Era A., Senzolo M., Abraldes J.G., Romero-Gomez M., Zipprich A., Casas M., Masnou H., Primignani M., Weiss E., Catalina M.-V., Erasmus H.-P., Uschner F.E., Schulz M., Brol M.J., Praktiknjo M., Chang J., Krag A., Nevens F., Calleja J.L., Robic M.A., Conejo I., Albillos A., Rudler M., Alvarado E., Guardascione M.A., Tantau M., Bosch J., Torres F., Pavesi M., Garcia-Pagan J.C., Jansen C., Banares R. (2020) Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J HEPATOL, 73 (5), 1082-1091.
IF: 25,083
Trebicka J., Fernandez J., Papp M., Caraceni P., Laleman W., Gambino C., Giovo I., Uschner F.E., Jimenez C., Mookerjee R., Gustot T., Albillos A., Banares R., Janicko M., Steib C., Reiberger T., Acevedo J., Gatti P., Bernal W., Zeuzem S., Zipprich A., Piano S., Berg T., Bruns T., Bendtsen F., Coenraad M., Merli M., Stauber R., Zoller H., Ramos J.P., Sole C., Soriano G., de Gottardi A., Gronbaek H., Saliba F., Trautwein C., Ozdogan O.C., Francque S., Ryder S., Nahon P., Romero-Gomez M., Van Vlierberghe H., Francoz C., Manns M., Garcia E., Tufoni M., Amoros A., Pavesi M., Sanchez C., Curto A., Pitarch C., Putignano A., Moreno E., Shawcross D., Aguilar F., Claria J., Ponzo P., Jansen C., Vitalis Z., Zaccherini G., Balogh B., Vargas V., Montagnese S., Alessandria C., Bernardi M., Gines P., Jalan R., Moreau R., Angeli P., Arroyo V., Maschmeier M., Semela D., Elkrief L., Elsharkawy A., Tornai T., Tornai I., Altorjay I., Antognoli A., Baldassarre M., Gagliardi M., Bertoli E., Mareso S., Brocca A., Campion D., Saracco G.M., Rizzo M., Lehmann J., Pohlmann A., Praktiknjo M., Schierwagen R., Sola E., Amari N., Rodriguez M., Nevens F., Clemente A., Jarcuska P., Gerbes A., Mandorfer M., Welsch C., Ciraci E., Patel V., Ripoll C., Herber A., Horn P., Danielsen K.V., Gluud L.L., Schaapman J., Riggio O., Rainer F., Moritz J.T., Mesquita M., Alvarado-Tapias E., Akpata O., Lykke Eriksen P., Samuel D., Tresson S., Strnad P., Amathieu R., Simon-Talero M., Smits F., van den Ende N., Martinez J., Garcia R., Markwardt D., Rupprechter H., Engelmann C. (2020) The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J HEPATOL, 73 (4), 842-854.
IF: 25,083
Turco L., Villanueva C., La Mura V., Garcia-Pagan J.C., Reiberger T., Genesca J., Groszmann R.J., Sharma B.C., Merkel C., Bureau C., Alvarado E., Abraldes J.G., Albillos A., Banares R., Peck-Radosavljevic M., Augustin S., Sarin S.K., Bosch J., Garcia-Tsao G. (2020) Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis. CLIN GASTROENTEROL H, 18 (2), 313-327.e6.
IF: 11,382
Zabana, Y; Rodriguez, L; Lobaton, T; Gordillo, J; Montserrat, A; Mena, R; Beltran, B; Dotti, M (; Benitez, O; Guardiola, J; Domenech, E; Garcia-Planella, E Calvet, X (; Piqueras, M;Aceituno, Montserrat; Fernandez-Banares, Fernando, Esteve, Maria. Relevant Infections in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their Effects on Disease Mortality. JOURNAL OF CROHNS & COLITIS; Volumen: 13 Número: 7 Páginas: 828-837. DO: 10.1093/ecco-jcc/jjz013. PMID: 30668662.
IF: 9,071
Weersink RA, Alvarez-Alvarez I, Medina-Cáliz I, Sanabria-Cabrera J, Robles-Díaz M, Ortega-Alonso A, García-Cortés M, Bonilla E, Niu H, Soriano G, Jimenez-Perez M, Hallal H, Blanco S, Kaplowitz N, Lucena MI, Andrade RJ. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old. CLIN PHARMACOL THER. 2020 Nov 11. doi: 10.1002/cpt.2108. PMID: 33179256.
IF: 6,875